Muhammed Razmi T, MD, DNB, Davinder Parsad, MD, Sendhil M. Kumaran, MD

Slides:

Advertisements

Similar presentations

Primary cutaneous anaplastic large cell lymphoma in a patient receiving adalimumab Chad J. Hruska, MD, Robert J. Bertoli, MD, Yorke D. Young, MD, Patrick.

Advertisements

Surgical margins for melanoma in situ

Molluscum contagiosum infection during the treatment of vitiligo with tacrolimus ointment Bong Kyun Ahn, MD, Byoung-Dae Kim, MD, Sang Ju Lee, MD, Seung.

Treatment of superficial basal cell carcinoma and squamous cell carcinoma in situ on the trunk and extremities with ablative fractional laser-assisted.

Lauren Kwa, BA, Jonathan I. Silverberg, MD, PhD, MPH

A girl with a solitary red bulla

Yul W. Yang, MD, PhD, David J. DiCaudo, MD

Dermoscopic features of acral melanocytic nevi in patients with skin types V and VI: A cross-sectional study Liza Gill, BS, Steven Wang, MD, Silvia E.

Blaschkoid pityriasis rosea

Baldness reversed by chemotherapy

Megan Wood, MD, Tom Raisanen, MD, Ingrid Polcari, MD

Array of cutaneous adverse effects associated with sorafenib

Elana Putterman, BS, Leslie Castelo-Soccio, MD, PhD

Sarah Sung, MD, Alexa B. Kimball, MD, MPH

María Jesús Suárez Valladares, MD, Manuel Ángel Rodríguez Prieto, MD

The impact of secukinumab treatment on the prevalence of human papillomavirus in patients with psoriasis: A pilot study Hsien-Yi Chiu, MD, Tsen-Fang.

Clindamycin-induced Sweet syndrome

Katherine E. Brick, BS, Robert H. Cook-Norris, MD, David A

Khanh P. Thieu, BS, Harley A. Haynes, MD

Effect of appearance-based education compared with health-based education on sunscreen use and knowledge: A randomized controlled trial William Tuong,

Volume 3, Issue 6, Pages (November 2017)

Pharmacy costs of specialty medications for plaque psoriasis in the United States Eric J. Yang, BS, Kristen M. Beck, MD, Sahil Sekhon, MD, Tina Bhutani,

A pilot trial of treprostinil for the treatment and prevention of digital ulcers in patients with systemic sclerosis Lorinda Chung, MD, David Fiorentino,

Toxic epidermal necrolysis secondary to emergency contraceptive pills

Clinical and photographic assessment of lichen planopilaris treatment efficacy Aline Donati, MD, Philipe Assouly, MD, Bruno Matard, MD, Corinne Jouanique,

Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib: A 32-week open- label extension study with optional narrow-band ultraviolet.

A survey-based study on nail examinations at an American Academy of Dermatology free skin cancer screening Dayoung Ko, BS, Shari R. Lipner, MD, PhD

SALT II: A new take on the Severity of Alopecia Tool (SALT) for determining percentage scalp hair loss Elise A. Olsen, MD, Douglas Canfield, BS Journal.

Fever, eosinophilia, and a rash

Repigmentation of hair associated with melanoma in situ of scalp

Loss of efficacy of secukinumab for psoriasis at 24 to 32 weeks

Catherine G. Chung, MD, Eric E. Jung, BS, Klaus F. Helm, MD

Infectious rash after riding elephants

Lenalidomide in treatment-refractory cutaneous lupus erythematosus: Efficacy and safety in a 52-week trial Lauren Okon, MD, Misha Rosenbach, MD, Michael.

Molluscum contagiosum infection during the treatment of vitiligo with tacrolimus ointment Bong Kyun Ahn, MD, Byoung-Dae Kim, MD, Sang Ju Lee, MD, Seung.

Lip edema Journal of the American Academy of Dermatology

Adult-onset multiple myofibromas

Lip and oral mucosal lesions in 100 renal transplant recipients

Surgical Pearl: Tomato–an alternative model for shave biopsy training

Jeffrey Freed, MD, Jennifer Smith, MD

Eva Wang, BS, John Koo, MD, Elie Levy, MD

Gina Francisco, MBS, Babar K. Rao, MD, Frank C. Victor, MD

Isotretinoin for high-grade or refractory epidermal growth factor receptor inhibitor-related acneiform papulopustular eruptions Herbert C. Chiang, MD,

Evaluation of Repigmentation with Cultured Melanocyte Transplantation (CMT) Compared with Non-Cultured Epidermal Cell Transplantation in Vitiligo at 12th.

Olga Vornicova, MD, Gil Bar-Sela, MD JAAD Case Reports

Pooja H. Rambhia, BA, Ivan J. Stojanov, DMD, Joshua Arbesman, MD

Hugh Gloster, MD, Chesahna Kindred, MBA

Medicaid acceptance among pediatric dermatologists

NUT midline carcinoma with cutaneous metastases

Oral allergy syndrome and contact urticaria to apples

Penile calciphylaxis Journal of the American Academy of Dermatology

Christopher T. Cassetty, MD, Andrew F. Alexis, MD, MPH, Jerome L

Volume 3, Issue 6, Pages (November 2017)

Modification of the nail psoriasis severity index

Tofacitinib therapy for children with severe alopecia areata

Jose Fernández-Vozmediano, PhD, Jose Armario-Hita, MD

Michelle A. Pipitone, MD, Brian Adams, MD, MPH, Anita Sheth, MD, T

A simple algorithm for evaluating dermatologic disease in critically ill patients: A study based on retrospective review of medical intensive care unit.

Circulatory levels of T-cell cytokines (interleukin [IL]-2, IL-4, IL-17, and transforming growth factor-β) in patients with vitiligo Rehan Khan, MSc,

Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA) John E. Harris, MD, PhD, Mehdi Rashighi,

Eyebrow transplantation: Alternative body sites as a donor source

Recurrence of nevus depigmentosus after an autologous epidermal graft

Gaps in pain management in dermatology: A needs assessment from Canada

A grayscale photograph with high dynamic range taken under a Wood's lamp for better recognition of vitiligo lesions Jung Min Bae, MD, PhD, Tae Young.

Brittany G. Craiglow, MD, Brett A. King, MD, PhD

Randomized study of topical tacrolimus ointment as possible treatment for resistant idiopathic pruritus ani Erwin Suys, MD Journal of the American Academy.

“Boot foot” with pseudomonas colonization

Orit Kaidar-Person, MD, Ayelet Eran, MD, Gil Bar-Sela, MD

Stuart M. Goldsmith, MD, Armand B. Cognetta, MD

Electrocoagulation and hazardous damage to a dental prosthesis

Presentation transcript:

Combined epidermal and follicular cell suspension as a novel surgical approach for acral vitiligo Muhammed Razmi T, MD, DNB, Davinder Parsad, MD, Sendhil M. Kumaran, MD Journal of the American Academy of Dermatology Volume 76, Issue 3, Pages 564-567 (March 2017) DOI: 10.1016/j.jaad.2016.10.004 Copyright © 2016 American Academy of Dermatology, Inc. Terms and Conditions

Fig 1 Depigmented patches on the left (A) and right (D) iliac crests of patient 5. After 16 weeks, combined epidermal cell suspension (ECS) and follicular cell suspension (FCS) side (B) attained more than 90% repigmentation while ECS (E) side attained only 75% to 90% repigmentation. Objective analysis of repigmentation at week 16 using software (Adobe Reader 11.0 for Windows, Adobe Systems Inc, San Jose, CA) showed 99% repigmentation over combined ECS and FCS side (C) and 82% repigmentation on ECS side (F). The area under repigmented portion (black lines) and nonpigmented portion (red lines) was measured as percentages of total lesional area using area tool in the measuring tool option of Adobe Reader 11.0 for Windows software (Adobe Systems Inc). Journal of the American Academy of Dermatology 2017 76, 564-567DOI: (10.1016/j.jaad.2016.10.004) Copyright © 2016 American Academy of Dermatology, Inc. Terms and Conditions